These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 15465071)
1. The adjustment to illness in patients with generalized anxiety disorder is poorer than that in patients with end-stage renal disease. Lieh Yeh T; Liang Huang C; Kuang Yang Y; Dar Lee Y; Cheng Chen C; See Chen P J Psychosom Res; 2004 Aug; 57(2):165-70. PubMed ID: 15465071 [TBL] [Abstract][Full Text] [Related]
2. Anxiety disorders in adults treated by hemodialysis: a single-center study. Cukor D; Coplan J; Brown C; Friedman S; Newville H; Safier M; Spielman LA; Peterson RA; Kimmel PL Am J Kidney Dis; 2008 Jul; 52(1):128-36. PubMed ID: 18440682 [TBL] [Abstract][Full Text] [Related]
8. Feasibility and utility of screening for depression and anxiety disorders in patients with cardiovascular disease. Celano CM; Suarez L; Mastromauro C; Januzzi JL; Huffman JC Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):498-504. PubMed ID: 23759474 [TBL] [Abstract][Full Text] [Related]
9. [The prevalence of generalized anxiety disorder and comorbidity among psychiatric outpatients]. Ozcan M; Uğuz F; Cilli AS Turk Psikiyatri Derg; 2006; 17(4):276-85. PubMed ID: 17183444 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial. Rynn M; Russell J; Erickson J; Detke MJ; Ball S; Dinkel J; Rickels K; Raskin J Depress Anxiety; 2008; 25(3):182-9. PubMed ID: 17311303 [TBL] [Abstract][Full Text] [Related]
11. Gender differences in clinical presentation and response to sertraline treatment of generalized anxiety disorder. Steiner M; Allgulander C; Ravindran A; Kosar H; Burt T; Austin C Hum Psychopharmacol; 2005 Jan; 20(1):3-13. PubMed ID: 15551351 [TBL] [Abstract][Full Text] [Related]
12. Predictors of psychosocial adjustment in people with physical disease. Kocaman N; Kutlu Y; Ozkan M; Ozkan S J Clin Nurs; 2007 Mar; 16(3A):6-16. PubMed ID: 17518864 [TBL] [Abstract][Full Text] [Related]
13. The construct of generalized anxiety disorder in Alzheimer disease. Starkstein SE; Jorge R; Petracca G; Robinson RG Am J Geriatr Psychiatry; 2007 Jan; 15(1):42-9. PubMed ID: 17194814 [TBL] [Abstract][Full Text] [Related]
14. Worry exposure versus applied relaxation in the treatment of generalized anxiety disorder. Hoyer J; Beesdo K; Gloster AT; Runge J; Höfler M; Becker ES Psychother Psychosom; 2009; 78(2):106-15. PubMed ID: 19218829 [TBL] [Abstract][Full Text] [Related]
15. Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial. Katzman MA; Vermani M; Jacobs L; Marcus M; Kong B; Lessard S; Galarraga W; Struzik L; Gendron A J Anxiety Disord; 2008 Dec; 22(8):1480-6. PubMed ID: 18455360 [TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal symptoms in primary care: prevalence and association with depression and anxiety. Mussell M; Kroenke K; Spitzer RL; Williams JB; Herzog W; Löwe B J Psychosom Res; 2008 Jun; 64(6):605-12. PubMed ID: 18501261 [TBL] [Abstract][Full Text] [Related]
17. Putative temperament of patients with generalized anxiety disorder: two-years' interval test-retest reliability of a Japanese version of the Generalized Anxious Temperament. Osone A; Takahashi S Psychiatry Clin Neurosci; 2006 Feb; 60(1):96-102. PubMed ID: 16472365 [TBL] [Abstract][Full Text] [Related]
18. Escitalopram in the treatment of anxiety symptoms associated with depression. Bandelow B; Andersen HF; Dolberg OT Depress Anxiety; 2007; 24(1):53-61. PubMed ID: 16937393 [TBL] [Abstract][Full Text] [Related]
19. Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder. Demyttenaere K; Andersen HF; Reines EH Int Clin Psychopharmacol; 2008 Sep; 23(5):276-86. PubMed ID: 18703937 [TBL] [Abstract][Full Text] [Related]
20. [Prevalence and correlates of anxiety and depression in patients with end-stage renal disease (ESRD)]. Reckert A; Hinrichs J; Pavenstädt H; Frye B; Heuft G Z Psychosom Med Psychother; 2013; 59(2):170-88. PubMed ID: 23775555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]